Analysis of Biomarkers From Patients With Chorioretinal Diseases

N/ARecruitingNCT02026843

Kyungpook National University Hospital100 enrolled

Overview

This study was conducted to investigate the levels of ocular biomarkers from the patients with chorioretinal diseases including diabetic retinopathy, retinal vascular diseases, age-related macular degeneration (dry and wet), and retinal degeneration.

This prospective, case-control study included 50 patients(50eyes) with chorioretinal diseases including diabetic retinopathy, retinal vascular diseases, age-related macular degeneration (dry and wet), and retinal degeneration. and 50 patient with nondiabetic retinopathy or cataract. Ocular fluids and blood samples were taken before injection of anti-vascular endothelial growth factor agent or pars plana vitrectomy for other retinal disease. Ocular biomarkers were analyzed.

Study Type

OBSERVATIONAL

Enrollment

100

Conditions

Diabetic Retinopathy Macular Degeneration

Interventions

Chorioretinal diseasesDRUG

chorioretinal diseases including diabetic retinopathy, retinal vascular diseases, age-related macular degeneration (dry and wet), and retinal degeneration

Eligibility

Sex: ALLMin age: 20 YearsMax age: 80 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * age over 20 years * patients requiring ophthalmologic treatments for different degrees of decreasing of visual acuity. * patients with chorioretinal diseases including diabetic retinopathy, retinal vascular diseases, age-related macular degeneration (dry and wet), and retinal degeneration. * control patients asking cataract surgery or vitrectomy for posterior segment nonproliferative disorders. Exclusion Criteria: * under the age of 20 years * patients that received any anti-vascular endothelial growth factor agent for proliferative disease before taking sample of aqueous humor * patients that did not signed the informed consent of the trial * patients with intraocular inflammations or infections that requiring any pharmaceutical agent * patients with recent ocular trauma

Locations (1)

Dong Ho Park

Daegu, Kyungsangpookdo, South Korea

RECRUITING

Outcomes

Primary Outcomes

Biomarkers in ocular fluids

To establish if certain type of chorioretinal diseases group are associated to different concentrations of gene or protein concentration.

Time frame: one month

Central Contacts

Dong Ho Park, M.D.

CONTACT

82-53-420-5813 sarasate2222@gmail.com

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.